Fig. 2

Our method contains two parts: a Identify mouse phenotype profiles for GBM and all approved drugs, and b Rank candidate drugs by mouse phenotype similarities with GBM
Our method contains two parts: a Identify mouse phenotype profiles for GBM and all approved drugs, and b Rank candidate drugs by mouse phenotype similarities with GBM